Put Warnings About Liver Damage With Hep C Meds Into Perspective

You'll hear about a link between hepatitis C meds and liver damage...especially in patients who also have hepatitis B.

FDA now requires a boxed warning about the risk of hepatitis B reactivation with newer hep C meds...Epclusa, Harvoni, Zepatier, etc.

And a recent report from Institute for Safe Medication Practices warns about rare cases of liver injury and failure tied to these meds.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals